[go: up one dir, main page]

MA27973A1 - Antagonistes du recepteur de l'acetylcholine muscarinique - Google Patents

Antagonistes du recepteur de l'acetylcholine muscarinique

Info

Publication number
MA27973A1
MA27973A1 MA28706A MA28706A MA27973A1 MA 27973 A1 MA27973 A1 MA 27973A1 MA 28706 A MA28706 A MA 28706A MA 28706 A MA28706 A MA 28706A MA 27973 A1 MA27973 A1 MA 27973A1
Authority
MA
Morocco
Prior art keywords
antagonists
muscarinic receptor
acetylcholine muscarinic
acetylcholine
receptor
Prior art date
Application number
MA28706A
Other languages
English (en)
Inventor
Kristen E Belmonte
Jakob Busch-Petersen
Dramane Laine
Michael R Palovich
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA27973A1 publication Critical patent/MA27973A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Des antagonistes des récepteurs d'acétylcholine muscariniques et des méthodes pour leur utilisation sont décrits.
MA28706A 2003-07-17 2006-01-06 Antagonistes du recepteur de l'acetylcholine muscarinique MA27973A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48806103P 2003-07-17 2003-07-17

Publications (1)

Publication Number Publication Date
MA27973A1 true MA27973A1 (fr) 2006-07-03

Family

ID=34102742

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28706A MA27973A1 (fr) 2003-07-17 2006-01-06 Antagonistes du recepteur de l'acetylcholine muscarinique

Country Status (18)

Country Link
US (1) US20060160844A1 (fr)
EP (1) EP1648462A4 (fr)
JP (1) JP2007535477A (fr)
KR (1) KR20060054317A (fr)
CN (1) CN1822840A (fr)
AR (1) AR048573A1 (fr)
AU (1) AU2004259239A1 (fr)
BR (1) BRPI0412679A (fr)
CA (1) CA2532379A1 (fr)
IL (1) IL172911A0 (fr)
IS (1) IS8297A (fr)
MA (1) MA27973A1 (fr)
MX (1) MXPA06000664A (fr)
NO (1) NO20060776L (fr)
PE (1) PE20050711A1 (fr)
RU (1) RU2006104854A (fr)
TW (1) TW200519109A (fr)
WO (1) WO2005009440A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
PE20050963A1 (es) * 2003-10-14 2006-01-11 Glaxo Group Ltd Compuestos derivados de 8-azoniabiciclo [3.2.1]octanos como antagonistas de receptores de acetilcolina muscarinicos
UY28567A1 (es) * 2003-10-17 2005-05-31 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005087236A1 (fr) * 2004-03-11 2005-09-22 Glaxo Group Limited Nouveaux antagonistes du recepteur de l'acetylcholine muscarinique m3
US7384946B2 (en) * 2004-03-17 2008-06-10 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
EP1725238A4 (fr) * 2004-03-17 2009-04-01 Glaxo Group Ltd Antagonistes du recepteur muscarinique a l'acetylcholine m 3
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
US7598267B2 (en) * 2004-05-13 2009-10-06 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
EP1957075A4 (fr) * 2004-11-15 2009-11-18 Glaxo Group Ltd Nouveaux antagonistes des recepteurs muscariniques de type m3 de l'acetylcholine
EP1888064B1 (fr) * 2005-06-10 2011-04-13 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Analogues de la benztropinamine utilises comme inhibiteurs de la capture de la dopamine
US20080275079A1 (en) * 2005-08-02 2008-11-06 Glaxo Group Limited M3 Muscarinic Acetylcholine Receptor Antagonists
JP2009504768A (ja) 2005-08-18 2009-02-05 グラクソ グループ リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
WO2007025055A2 (fr) 2005-08-24 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Composes de benztropine et leurs utilisations
CL2009000250A1 (es) 2008-02-06 2009-09-11 Glaxo Group Ltd Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis.
AR070563A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
WO2010094643A1 (fr) 2009-02-17 2010-08-26 Glaxo Group Limited Dérivés de quinoline et applications associées dans la rhinite et l'urticaire

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800482A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2415468A1 (fr) * 2000-07-11 2003-01-10 Yoshio Ogino Derives d'ester
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
CN1571787A (zh) * 2001-10-17 2005-01-26 Ucb公司 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途
JP4851937B2 (ja) * 2003-11-21 2012-01-11 セラヴァンス， インコーポレーテッド β２アドレナリン作動性受容体作動薬活性およびムスカリン受容体拮抗薬活性を有する化合物

Also Published As

Publication number Publication date
RU2006104854A (ru) 2006-06-27
JP2007535477A (ja) 2007-12-06
PE20050711A1 (es) 2005-09-10
MXPA06000664A (es) 2006-03-30
IL172911A0 (en) 2006-06-11
BRPI0412679A (pt) 2006-10-03
CN1822840A (zh) 2006-08-23
WO2005009440A1 (fr) 2005-02-03
IS8297A (is) 2006-02-13
TW200519109A (en) 2005-06-16
KR20060054317A (ko) 2006-05-22
NO20060776L (no) 2006-04-11
EP1648462A4 (fr) 2009-04-08
EP1648462A1 (fr) 2006-04-26
US20060160844A1 (en) 2006-07-20
AR048573A1 (es) 2006-05-10
CA2532379A1 (fr) 2005-02-03
AU2004259239A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
MA27973A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28110A1 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
MA27900A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA27901A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28109A1 (fr) Antagonistes du recepteur acetylcholine muscarinique
MA28218A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
MA28217A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
MY144753A (en) Muscarinic acetylcholine receptor antagonists
CY1113295T1 (el) Ανταγωνιστες m3 μουσκαρινικου υποδοχεα ακετυλοχολινης
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l&#39;acetylcholine
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
EP1675671A4 (fr) Synthese facile d&#39;anions polyedres de silsesquioxane, et leur utilisation
EP1809646A4 (fr) Riboswitches de glycine, méthodes d&#39;utilisation et compositions s&#39;utilisant avec les riboswitches
EP1765990A4 (fr) Agents therapeutiques, prophylactiques et diagnostiques pour l&#39;hepatite b